Search
for

    Sort by

    Research 31–60 of 235

    1. Lady with Long Eyelashes…! International Journal of Trichology · 2022
    2. Are all adverse effects undesirable? a case of chemotherapy induced adverse effect- an exception!? International journal of basic and clinical pharmacology · 2021
    3. Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR Revista Medicina Cutánea Ibero-Latino-Americana · 2021
    4. Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique 2011
    5. Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer Journal of thoracic oncology · 2010 · 12 citations
    6. A linear and reticulate crusted keratotic papulopustular eruption: a rare presentation of PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) complex Postgraduate Medical Journal · 2024
    7. The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists? Acta ophthalmologica · 2012 · 54 citations
    8. Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer Research Square (Research Square) · 2021
    9. Pancreatic cancer Nursing Made Incredibly Easy! · 2014
    10. Reporting on Adverse Clinical Events Clin-alert · 2008
    11. Cetuximab-Associated Elongation of the Eyelashes American Journal of Clinical Dermatology · 2010 · 30 citations
    12. Medication-Induced Repigmentation of Gray Hair: A Systematic Review Skin appendage disorders · 2019 · 28 citations
    13. Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts Clinics in Dermatology · 2011 · 19 citations
    14. Dermatologic Reactions to Targeted Therapy Nursing Clinics of North America · 2017 · 15 citations
    15. Hypertrichosis of the pinnae in a patient using panitumumab 2018 · 4 citations
    16. Management of Toxicities of Targeted Therapies Elsevier eBooks · 2018 · 2 citations
    17. PRIDE syndrome with lumbosacral hypertrichosis Dermatology Review · 2022
    18. A prospective observational study on drug safety monitoring and Pharmacoeconomics in patients with locally advanced unresectable NSCLC in a tertiary care hospital International journal of basic and clinical pharmacology · 2018
    19. Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails American Journal of Clinical Dermatology · 2018 · 179 citations
    20. Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases International Journal of Pharmaceutics · 2018 · 151 citations
    21. Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors Clinical Cancer Research · 2013 · 136 citations
    22. Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer Journal of the American Academy of Dermatology · 2014 · 88 citations
    23. Acne and Systemic Disease Medical Clinics of North America · 2009 · 76 citations
    24. Folliculitis decalvans: a multicentre review of 82 patients Journal of the European Academy of Dermatology and Venereology · 2015 · 68 citations
    25. Hair disorders in patients with cancer Journal of The American Academy of Dermatology · 2018 · 53 citations
    26. Drug-induced acne Clinics in Dermatology · 2016 · 52 citations
    27. Chemotherapy‐induced alopecia management: Clinical experience and practical advice Journal of Cosmetic Dermatology · 2017 · 48 citations
    28. Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review) Oncology Reports · 2012 · 46 citations
    29. Alopecia in patients treated with molecularly targeted anticancer therapies Annals of Oncology · 2015 · 44 citations
    30. Advances in the Management of Cutaneous Toxicities of Targeted Therapies Seminars in Oncology · 2012 · 42 citations